| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/27/2007 | US20070224271 Healing powder and method of use thereof |
| 09/27/2007 | US20070224270 Nicotinic Acid Compositions For Treating Hyperlipidemia and Related Methods Therefor |
| 09/27/2007 | US20070224269 Controlled Release Pharmaceutical Formulation |
| 09/27/2007 | US20070224268 Process for preparing oral calcium compositions |
| 09/27/2007 | US20070224267 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
| 09/27/2007 | US20070224266 Descarbonylethoxyloratadine containing pharmaceutical composition |
| 09/27/2007 | US20070224265 Tablet Comprising Branched Chain Amino Acid and Method for Producing the Same |
| 09/27/2007 | US20070224264 Remote Control Release of Encapsulated Material |
| 09/27/2007 | US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 09/27/2007 | US20070224261 Eutectic liquid drug formulation |
| 09/27/2007 | US20070224260 Dosage Form Having Polymorphic Stability |
| 09/27/2007 | US20070224259 Anti-inflammatory pharmaceutical composition |
| 09/27/2007 | US20070224258 Dosage forms having a randomized coating |
| 09/27/2007 | US20070224257 Brucellosis dna vaccine |
| 09/27/2007 | US20070224256 unit dosage form containing a pharmaceutically acceptable carrier and synthetic or semi-synthetic phosphatidylserine-carrying bodies having a three-dimensional structure, sized and shaped to resemble apoptotic cells and apoptotic bodies; useful for treating autoimmune diseases; antiinflammatory agent |
| 09/27/2007 | US20070224255 Liposomal Formulations |
| 09/27/2007 | US20070224254 Transdermal delivery patch |
| 09/27/2007 | US20070224253 Transdermal Delivery of Meptazinol |
| 09/27/2007 | US20070224252 Microprojections with capillary control features and method |
| 09/27/2007 | US20070224250 Mold-resistant construction materials |
| 09/27/2007 | US20070224249 Substantially dry disposable device for creating ready-to-use solutions for cleaning and inhibiting the formation of biofilms on surfaces |
| 09/27/2007 | US20070224228 Soap Bars Having Ultraviolet Radiation Protection |
| 09/27/2007 | US20070224226 Composition and method of use thereof |
| 09/27/2007 | US20070224225 Immune Response Stimulating Composition Comprising Nanoparticles Based on a Methyl Vinyl Ether-Maleic Acid Copolymer |
| 09/27/2007 | US20070224220 Intranasal or inhalational administration of virosomes |
| 09/27/2007 | US20070224215 Brown seaweed extracts in capsules consisting of broad-spectrum freeze dried antioxidant concentrates, Fucoidan, crystalloidals, Mangosteen, hyaluronic acid, alpha lipoic acid, green tea extract, vitamin C, and black pepper extract with delivery systems for utilization of nutrients |
| 09/27/2007 | US20070224214 Composition Exerting Physiological Activity Via Biological Immune Mechanism |
| 09/27/2007 | US20070224204 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 09/27/2007 | US20070224175 Salt and pH tunable resist patterns on polyelectrolyte multilayers |
| 09/27/2007 | US20070224173 Nonexpansion Protocol for Autologous Cell-Based Therapies |
| 09/27/2007 | US20070224169 Selectively switched gels for surgery, therapy and maintenance |
| 09/27/2007 | US20070224159 Ophthalmic Compositions Containing A Synergistic Combination Of Three Polymers |
| 09/27/2007 | US20070224129 Anti-misuse microparticulate oral pharmaceutical form |
| 09/27/2007 | US20070222842 Ejection Liquid, Ejection Device, Ejection Cartridge, and Method of Making Droplets From Liquid |
| 09/27/2007 | US20070221217 Container for an inhalation anesthetic |
| 09/27/2007 | DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts |
| 09/27/2007 | DE202007008849U1 Korkmaterial mit Rohdiamant-Partikeln Cork with rough diamond particles |
| 09/27/2007 | DE102006013531A1 Polylactid-Nanopartikel Polylactide nanoparticles |
| 09/27/2007 | CA2647089A1 Association of oleaginous substance with a mixture of at least two cyclodextrins |
| 09/27/2007 | CA2646424A1 Stabilized ophtalmic compositions comprising oxidatively unstable components |
| 09/27/2007 | CA2646156A1 Treatment of triple receptor negative breast cancer |
| 09/27/2007 | CA2646067A1 Stabilized, sterilized collagen scaffolds with active adjuncts attached |
| 09/27/2007 | CA2645940A1 Controlled release formulation of tolterodine |
| 09/27/2007 | CA2645855A1 Modified release formulations containing drug-ion exchange resin complexes |
| 09/27/2007 | CA2645603A1 Dosage forms having a randomized coating |
| 09/27/2007 | CA2645566A1 Pharmaceutical compositions |
| 09/27/2007 | CA2645324A1 Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof |
| 09/27/2007 | CA2645203A1 Microparticles comprising a crosslinked polymer |
| 09/27/2007 | CA2643944A1 Solid dosage form containing a taste masked active agent |
| 09/27/2007 | CA2642759A1 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue |
| 09/26/2007 | EP1837040A2 Drug delivery matrices to enhance wound healing |
| 09/26/2007 | EP1837035A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 09/26/2007 | EP1837023A1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 09/26/2007 | EP1837021A2 Inhalative solution formulation containing a tiotropium salt |
| 09/26/2007 | EP1837020A1 Mucosal bioadhesive slow release carrier for delivering active principles |
| 09/26/2007 | EP1837019A1 Orally-dispersible pharmaceutical compositions |
| 09/26/2007 | EP1837018A1 Sustained release microspheres |
| 09/26/2007 | EP1837017A2 Microparticles for delivery of nucleic acid |
| 09/26/2007 | EP1837016A2 Pharmaceutical multiple-unit composition |
| 09/26/2007 | EP1837015A1 Novel core-shell structure |
| 09/26/2007 | EP1837014A1 Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue |
| 09/26/2007 | EP1836902A1 Extruded glassy vitamin C particles |
| 09/26/2007 | EP1836252A1 Amine polymer-modified nanoparticulate carriers |
| 09/26/2007 | EP1835923A2 Regimens for intra-articular viscosupplementation |
| 09/26/2007 | EP1835915A2 Immune response modifier formulations and methods |
| 09/26/2007 | EP1835911A2 Therapeutic compositions for intranasal administration of ketorolac |
| 09/26/2007 | EP1835903A1 Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same |
| 09/26/2007 | EP1835894A1 Solid lipidic particles as pharmadeutically acceptable fillers or carriers for inhalation |
| 09/26/2007 | EP1835893A1 Pharmaceutical composition containing coated, floating particles |
| 09/26/2007 | EP1835892A2 Chewable oral compositions containing an anti-microbial agent and methods of formulating the compositions to have acceptable germ kill properties and taste |
| 09/26/2007 | EP1835891A1 Solid pharmaceutical compositions |
| 09/26/2007 | EP1835890A2 Nanoparticulate candesartan formulations |
| 09/26/2007 | EP1835889A1 Nanoparticulate tacrolimus formulations |
| 09/26/2007 | EP1835888A1 Cholanic acid-chitosan complex forming self-aggregates and preparation method thereof |
| 09/26/2007 | EP1835887A2 Mucoadhesive pharmaceutical compositions comprising chemoattractants |
| 09/26/2007 | EP1835886A1 Orally disintegrating pharmaceutical compositions with sensory cue agents |
| 09/26/2007 | EP1835885A1 Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
| 09/26/2007 | EP1835857A1 Formulations for coated microprojections having controlled solubility |
| 09/26/2007 | EP1753461B1 Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide |
| 09/26/2007 | EP1735006B1 Polymer particles containing active agents |
| 09/26/2007 | EP1567203B1 Barriers for bioactive agent-containing polymeric coatings |
| 09/26/2007 | EP1532981B1 Stable eye drops containing latanoprost as the active ingredient |
| 09/26/2007 | EP1501485B1 High drug load tablet |
| 09/26/2007 | EP1438040B1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 09/26/2007 | EP1408948B1 Thyroid therapeutic agent comprising partial glycerides and dextrine |
| 09/26/2007 | EP1353645B1 Method for the production and use of a cream containing vitamin-a. |
| 09/26/2007 | EP1313481B1 Pharmaceutical composition comprising condensed indole compound |
| 09/26/2007 | EP1307187B1 Use of 13-cis retinoic acid for the treatment of emphysema |
| 09/26/2007 | EP1301638B1 Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| 09/26/2007 | EP1265596B1 Medical emulsion for lubrication and delivery of drugs |
| 09/26/2007 | EP1140960B1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 09/26/2007 | EP1030560B1 Method and devices for transdermal delivery of lithium |
| 09/26/2007 | CN200951202Y External use magnetic traditional Chinese medicine plaster for treating cervical vertebrae ache disease |
| 09/26/2007 | CN200951201Y Medicated plaster for treating phlebitis |
| 09/26/2007 | CN200951200Y External use plaster with medicine ointment |
| 09/26/2007 | CN101043936A Process for producing microsphere with use of metal substrate having through-hole |
| 09/26/2007 | CN101043906A Compositions and methods for nutrition supplementation |
| 09/26/2007 | CN101043897A Chinese pharmaceutical compositions for treating epidemic cerebrospinal meningitis and processes for preparation thereof |
| 09/26/2007 | CN101043880A Pharmaceutical composition comprising diclofenac |
| 09/26/2007 | CN101043879A Pharmaceutical formulations of potassium atp channel openers and uses thereof |